APA (7th ed.) Citation

Dai, L., Song, Q. Y., Zou, Y. W., Su, Y., Su, L. W., MA, J. D., . . . Jun, D. (2024). AB1446 ASSOCIATION OF GENETICALLY PROXIED JANUS KINASE INHIBITOR TARGETS WITH CARDIOVASCULAR RISK: A DRUG-TARGET MENDELIAN RANDOMIZATION STUDY. Annals of the rheumatic diseases, 83(Suppl 1), 2080-2081. https://doi.org/10.1136/annrheumdis-2024-eular.3664

Chicago Style (17th ed.) Citation

Dai, L., et al. "AB1446 ASSOCIATION OF GENETICALLY PROXIED JANUS KINASE INHIBITOR TARGETS WITH CARDIOVASCULAR RISK: A DRUG-TARGET MENDELIAN RANDOMIZATION STUDY." Annals of the Rheumatic Diseases 83, no. Suppl 1 (2024): 2080-2081. https://doi.org/10.1136/annrheumdis-2024-eular.3664.

MLA (9th ed.) Citation

Dai, L., et al. "AB1446 ASSOCIATION OF GENETICALLY PROXIED JANUS KINASE INHIBITOR TARGETS WITH CARDIOVASCULAR RISK: A DRUG-TARGET MENDELIAN RANDOMIZATION STUDY." Annals of the Rheumatic Diseases, vol. 83, no. Suppl 1, 2024, pp. 2080-2081, https://doi.org/10.1136/annrheumdis-2024-eular.3664.